Drugmaker Moves To Stop Natal Vitamin Reclassification

By Christopher Crosby · August 18, 2017, 2:06 PM EDT

A drugmaker hit a pharmaceutical information provider with a lawsuit in California federal court on Thursday, alleging that its upcoming decision to designate prenatal vitamins as nonprescription is a deceptive change...

To view the full article, register now.

Documents

Case Information

Case Title

Exeltis USA Inc. v. First Databank, Inc.

Case Number

3:17-cv-04810

Court

California Northern

Nature of Suit

Other Statutory Actions

Date Filed

August 17, 2017